Drug:
Reaction: BLOOD GLUCOSE INCREASED
20250101 - 20251231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 25116495 |
CO |
72 | 2 |
Vision blurred, Discouragement, Blood glucose increased, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, AMLODIPINE, IRBESARTAN, METOPROLOL TARTRATE, METOPROLOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 102 | 25116582 |
US |
70 | 1 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN GLARGINE, |
||||
| 103 | 25116788 |
US |
61 | 2 |
Product dose omission issue, Blood glucose increased, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 104 | 25117042 |
US |
1 | |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 105 | 25117046 |
US |
80 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 106 | 25117389 |
US |
54 | 1 |
Sepsis, Cholecystitis, Impaired gastric emptying, Cholelithiasis, Stress, Constipation, Diarrhoea, Blood glucose increased, Off label use, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LISINOPRIL, LEVOTHYROXINE, LEVOTHYROXINE, ERTUGLIFLOZIN, VARENICLINE TARTRATE, TESTOSTERONE CYPIONATE, METHYLPREDNISOLONE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 107 | 25117460 |
US |
54 | 1 |
Hunger, Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 108 | 25117580 |
RO |
44 | 2 |
Blood glucose increased, Neuropathy peripheral, Dermatitis bullous, Condition aggravated, |
||||
DOXORUBICIN, DACARBAZINE, |
||||
| 109 | 25117845 |
US |
65 | 1 |
Blood glucose increased, Accidental underdose, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 110 | 25117969 |
US |
64 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 111 | 25117971 |
US |
64 | 1 |
Cataract, Stress, Sinusitis, Inflammation, Hypertension, Weight decreased, Arthralgia, Blood glucose increased, Glycosylated haemoglobin increased, |
||||
INSULIN HUMAN, INSULIN HUMAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, GUAIFENESIN, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 112 | 25118051 |
GB |
85 | 2 |
Blood glucose increased, Thirst, Eye swelling, Swelling face, Erythema, Flushing, Tremor, |
||||
RANIBIZUMAB, |
||||
| 113 | 25118388 |
CO |
71 | 2 |
Urinary tract infection, Product availability issue, Blood glucose increased, Product dose omission issue, Restlessness, |
||||
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, AZACITIDINE, AZACITIDINE FOR, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, |
||||
| 114 | 25118397 |
US |
33 | 1 |
Multiple sclerosis, Upper respiratory tract infection, Bronchitis, Alanine aminotransferase increased, Blood calcium increased, Blood alkaline phosphatase increased, Anti-thyroid antibody increased, Thyroid stimulating immunoglobulin increased, Visual impairment, Diplopia, Ear pain, Oropharyngeal pain, Cough, Chest discomfort, Mucosal discolouration, Pharyngitis, Sluggishness, Erythema, Otitis media acute, Hypoacusis, Blood glucose increased, Fatigue, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, PREDNISONE, LEVOTHYROXINE, ALEMTUZUMAB, BACLOFEN, FLUTICASONE PROPIONATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, ERGOCALCIFEROL, ERGOCALCIFEROL, VITAMIN C, CIMETIDINE, LEVOTHYROXINE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, ARTIFICIAL TEARS, LUBRICANT EYE DROPS, POLYVINYL ALCOHOL, POVIDONE, GLYCERIN, MINERAL OIL, PETROLATUM, ERGOCALCIFEROL, ERGOCALCIFEROL, GLATIRAMER ACETATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, METHIMAZOLE, |
||||
| 115 | 25118540 |
US |
41 | 2 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 116 | 25118541 |
US |
51 | 1 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, LISINOPRIL, |
||||
| 117 | 25118663 |
DE |
||
Malignant neoplasm progression, Metastases to lung, Blood alkaline phosphatase increased, Gamma-glutamyltransferase increased, Pain, Initial insomnia, Nausea, Blood glucose increased, Blood lactate dehydrogenase increased, Aspartate aminotransferase increased, Blood calcium increased, Product use issue, |
||||
IVOSIDENIB, |
||||
| 118 | 25118831 |
JP |
||
Blood glucose increased, |
||||
CAPIVASERTIB, FULVESTRANT, FULVESTRANT, |
||||
| 119 | 25118931 |
US |
85 | 1 |
Fall, Blood glucose decreased, Blood glucose increased, Accidental underdose, |
||||
INSULIN LISPRO, |
||||
| 120 | 25118943 |
US |
||
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 121 | 25118997 |
US |
88 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 122 | 25119476 |
US |
39 | 1 |
Blood glucose increased, Incorrect dose administered, |
||||
DULAGLUTIDE, |
||||
| 123 | 25119480 |
US |
48 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 124 | 25119483 |
US |
31 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 125 | 25120030 |
US |
1 | |
Blood glucose increased, Memory impairment, |
||||
INSULIN LISPRO, |
||||
| 126 | 25120212 |
US |
34 | 2 |
Migraine, Blood glucose increased, Vomiting, Fatigue, Nausea, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 127 | 25120442 |
US |
||
Pneumonia, Blood glucose increased, Intentional dose omission, |
||||
GIVOSIRAN SODIUM, |
||||
| 128 | 25120513 |
US |
||
Blood glucose increased, Rash, |
||||
OLEZARSEN SODIUM, EVOLOCUMAB, |
||||
| 129 | 25120558 |
US |
54 | |
Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, |
||||
| 130 | 25120923 |
US |
74 | 1 |
Dizziness, Hidradenitis, Drug ineffective, Blood glucose increased, Therapeutic product effect decreased, Vertigo, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 131 | 25123674 |
78 | 1 | |
Drug ineffective, Asthenia, Fatigue, Asthenia, Somnolence, Loss of personal independence in daily activities, Apathy, Peripheral swelling, Erythema, Livedo reticularis, Cellulitis, Blood glucose increased, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL BISULFATE, ENALAPRIL, AMLODIPINE BESYLATE, |
||||
| 132 | 25109985 |
US |
71 | 1 |
Prostatectomy, Rash, Dysuria, Arthralgia, Blood glucose increased, Post procedural urine leak, |
||||
EMPAGLIFLOZIN, TIOTROPIUM BROMIDE, LISINOPRIL, BUDESONIDE AND FORMOTEROL FUMARATE, ROSUVASTATIN, |
||||
| 133 | 25110039 |
PT |
44 | 2 |
Blood glucose increased, Headache, Product substitution issue, |
||||
TRAZODONE HYDROCHLORIDE, |
||||
| 134 | 25110170 |
US |
64 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 135 | 25110409 |
BR |
1006 | 2 |
Blood glucose increased, Device leakage, Wrong technique in device usage process, |
||||
INSULIN DEGLUDEC, |
||||
| 136 | 25110563 |
US |
||
Diarrhoea, Rash, Blood glucose increased, White blood cell count decreased, |
||||
CAPIVASERTIB, LORATADINE, LORATADINE TABLET, |
||||
| 137 | 25110714 |
US |
66 | 1 |
Blood glucose increased, |
||||
INSULIN HUMAN, INSULIN HUMAN, |
||||
| 138 | 25110951 |
US |
72 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO-AABC, |
||||
| 139 | 25110952 |
US |
53 | 2 |
Gastrointestinal disorder, Drug ineffective, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, DULAGLUTIDE, INSULIN DETEMIR, INSULIN GLARGINE, ORAL SEMAGLUTIDE, |
||||
| 140 | 25111031 |
US |
2 | |
Blood glucose increased, |
||||
TEPROTUMUMAB, ERGOCALCIFEROL, DULAGLUTIDE, LORATADINE, LORATADINE TABLET, LORAZEPAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 141 | 25111058 |
GB |
83 | 2 |
Back pain, Nausea, Abdominal pain upper, Blood glucose increased, Amnesia, Blindness, Immunisation, Alopecia, Pyrexia, Tension headache, Migraine, Intentional product misuse, Intentional product use issue, Intentional product misuse, Off label use, Off label use, Product use issue, Medication error, Incorrect product administration duration, Product use in unapproved indication, Subarachnoid haemorrhage, Diarrhoea, Malaise, Abdominal discomfort, Headache, Nausea, Hallucination, Angioedema, Malaise, COVID-19, Dizziness, Tinnitus, Arthralgia, Pain of skin, Peripheral swelling, Disturbance in attention, Cognitive disorder, Memory impairment, Visual impairment, Blindness, Diplopia, Blindness, Vasculitis, Carotid artery occlusion, Transient ischaemic attack, Pruritus genital, Sleep terror, Fatigue, Vomiting, Ventricular tachycardia, Pericarditis, Cardiospasm, Dyspnoea, Atrial tachycardia, Fatigue, Anxiety, Muscular weakness, Feeling abnormal, Insomnia, Heart rate increased, Muscle twitching, Abdominal pain upper, Dehydration, Hyperhidrosis, Rash papular, Lip swelling, Pruritus, Palmoplantar keratoderma, Dry skin, Myocardial infarction, Chest pain, Palpitations, Tachycardia, Pain, Anosmia, Eye pruritus, Facial pain, Fatigue, Abdominal discomfort, |
||||
NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, DAPAGLIFLOZIN, DAPAGLIFLOZIN, ISOSORBIDE MONONITRATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, AMITRIPTYLINE HYDROCHLORIDE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUMETANIDE, |
||||
| 142 | 25111245 |
US |
1 | |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN ASPART, |
||||
| 143 | 25111313 |
TW |
48 | |
Nausea, Vomiting, Abdominal pain, Dyspnoea, Blood glucose increased, Urine ketone body present, Blood lactic acid increased, |
||||
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, TICAGRELOR, |
||||
| 144 | 25112863 |
IT |
75 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, LEVOTHYROXINE, RAMIPRIL, HALOPERIDOL, HALOPERIDOL LACTATE, LOVASTATIN, ROSUVASTATIN, |
||||
| 145 | 25112874 |
US |
54 | 1 |
Drug ineffective, Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, INSULIN GLARGINE, EMPAGLIFLOZIN, |
||||
| 146 | 25112901 |
CN |
57 | 2 |
Deafness neurosensory, Dry mouth, Polydipsia, Blood glucose fluctuation, Diabetic retinopathy, Diabetic neuropathy, Discomfort, Diabetes mellitus inadequate control, Blood fibrinogen increased, Blood glucose increased, Blood triglycerides increased, Glycated albumin increased, Pulmonary mass, Gallbladder polyp, Hypoaesthesia, Vision blurred, Chest discomfort, Tinnitus, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 147 | 25113389 |
US |
62 | 1 |
Psoriatic arthropathy, Blood glucose increased, Therapeutic product effect incomplete, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, GUSELKUMAB, IXEKIZUMAB, GLIPIZIDE, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, RISANKIZUMAB-RZAA, INSULIN GLARGINE, |
||||
| 148 | 25113513 |
US |
70 | 2 |
Visual impairment, Platelet count increased, Epistaxis, Blood glucose increased, Nephrolithiasis, Hydronephrosis, Off label use, |
||||
AVATROMBOPAG MALEATE, PREDNISONE, |
||||
| 149 | 25113607 |
AU |
62 | 2 |
Behaviour disorder, Blood albumin decreased, Blood creatinine increased, Blood glucose increased, Blood osmolarity increased, Blood thyroid stimulating hormone increased, C-reactive protein increased, Eosinophil count increased, Haemoglobin decreased, Lymphocyte count decreased, Mean cell haemoglobin decreased, Platelet count increased, Stress, Troponin increased, White blood cell count increased, |
||||
NITROGLYCERIN, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATENOLOL, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), FLUVOXAMINE MALEATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TELMISARTAN, |
||||
| 150 | 25113692 |
US |
2 | |
Blood glucose increased, Blood glucose decreased, Injection site pain, |
||||
INSULIN LISPRO, INSULIN LISPRO, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 151 | 25113709 |
US |
64 | 1 |
Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 152 | 25114139 |
US |
47 | 2 |
Blood glucose increased, |
||||
NIRMATRELVIR AND RITONAVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BENZONATATE, NEBIVOLOL HYDROCHLORIDE, INSULIN ASPART, INSULIN ASPART, |
||||
| 153 | 25114211 |
US |
2 | |
Blood glucose increased, Product storage error, |
||||
INSULIN GLARGINE AND LIXISENATIDE, |
||||
| 154 | 25114505 |
AU |
18 | 1 |
Tricuspid valve incompetence, Myocarditis, Red blood cell sedimentation rate increased, Anion gap decreased, Blood uric acid increased, Blood albumin decreased, Blood calcium increased, Adjusted calcium increased, Blood magnesium increased, C-reactive protein increased, Blood osmolarity increased, Troponin C increased, Bilirubin conjugated increased, Red blood cell count decreased, Haematocrit decreased, Haemoglobin decreased, Eosinophil count increased, Neutrophil count decreased, Chest pain, Blood glucose increased, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 155 | 25114894 |
US |
40 | |
Increased appetite, Glycosylated haemoglobin increased, Blood glucose increased, Drug ineffective, |
||||
EMPAGLIFLOZIN, DULAGLUTIDE, SEMAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 156 | 25115164 |
US |
2 | |
Loss of consciousness, Illness, Blood glucose increased, Product dose omission issue, |
||||
INSULIN GLARGINE, |
||||
| 157 | 25115331 |
US |
||
Asthenia, Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 158 | 25115366 |
US |
2 | |
Blood glucose increased, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 159 | 25109204 |
US |
74 | 1 |
Blood glucose increased, Incorrect dose administered, Device delivery system issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, EMPAGLIFLOZIN, |
||||
| 160 | 25109367 |
US |
57 | 1 |
Product dose omission issue, Injection site pain, Injection site mass, Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 161 | 25109465 |
US |
2 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 162 | 25109522 |
US |
43 | 2 |
Incorrect dose administered, Blood glucose increased, Blood glucose decreased, |
||||
INSULIN GLARGINE, |
||||
| 163 | 25107652 |
CA |
40 | |
Gamma-glutamyltransferase increased, Headache, Balance disorder, Tremor, Peripheral swelling, Urinary tract infection, Gait disturbance, Drug ineffective, Vision blurred, Weight increased, Migraine, Decreased activity, Dizziness, Blood pressure decreased, Depression, Burning sensation, Anxiety, Blood glucose increased, Paraesthesia, Fatigue, Bundle branch block right, Motor dysfunction, Tachycardia, Limb discomfort, Skin burning sensation, Hypertension, Diplopia, Hypokinesia, Multiple sclerosis, Product dose omission issue, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 164 | 25107993 |
US |
84 | 2 |
Blood glucose increased, Device issue, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 165 | 25108124 |
US |
68 | 1 |
Blood glucose increased, Product dispensing issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 166 | 25108654 |
US |
71 | 2 |
Blood glucose increased, |
||||
INSULIN HUMAN, |
||||
| 167 | 25109015 |
US |
61 | 1 |
Product storage error, Drug ineffective, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 168 | 25109019 |
US |
54 | 2 |
Oropharyngeal discomfort, Insomnia, Glycosylated haemoglobin increased, Blood glucose increased, Faeces hard, Malaise, Abdominal distension, Vomiting, Decreased appetite, Eructation, Gastrooesophageal reflux disease, Constipation, Abdominal pain upper, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 169 | 25109051 |
CO |
89 | 1 |
Blood glucose increased, Colitis, Product availability issue, Inappropriate schedule of product administration, Cholelithiasis, Incorrect dose administered, Blood glucose abnormal, Inappropriate schedule of product administration, Blood glucose increased, |
||||
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SITAGLIPTIN, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
| 170 | 25109105 |
US |
65 | 1 |
Extra dose administered, Drug ineffective, Blood glucose increased, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 171 | 25109126 |
US |
40 | 1 |
Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 172 | 25102574 |
US |
||
Blood glucose increased, |
||||
EXENATIDE, |
||||
| 173 | 25102592 |
US |
66 | 2 |
Myocardial infarction, Breast cancer recurrent, Loss of consciousness, Blood glucose decreased, Chest pain, Blood glucose increased, Blood glucose increased, Product prescribing error, Product dispensing error, |
||||
INSULIN ASPART, INSULIN GLARGINE, |
||||
| 174 | 25102636 |
US |
1 | |
Cerebrovascular accident, Blood glucose increased, |
||||
INSULIN ASPART, |
||||
| 175 | 25103135 |
GB |
54 | 2 |
Treatment failure, Blood glucose increased, |
||||
INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 176 | 25103758 |
US |
2 | |
Blood cholesterol increased, Decreased appetite, Blood glucose increased, Hot flush, Gait disturbance, Chills, Hyperhidrosis, Bone pain, Tremor, Fatigue, Headache, |
||||
ROSUVASTATIN, ZOLEDRONIC ACID, PALBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 177 | 25105026 |
50 | ||
Abdominal pain, Type 2 diabetes mellitus, Schizophrenia, Nasal congestion, Leukocytosis, Red cell distribution width increased, Platelet count increased, Monocyte count increased, Blood sodium decreased, Blood glucose increased, Blood urea decreased, Blood alkaline phosphatase increased, Emphysema, Hepatomegaly, Urethral disorder, Pain, Anxiety, Vitamin D decreased, Gastrointestinal disorder, Viral infection, Nausea, Diarrhoea, Cough, Vomiting, Drug ineffective, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, IBRUTINIB, IBRUTINIB, IBRUTINIB, IBRUTINIB, BELUMOSUDIL, BELUMOSUDIL, BELUMOSUDIL, BELUMOSUDIL, RITUXIMAB, BUDESONIDE, MONTELUKAST SODIUM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACYCLOVIR, CYCLOSPORINE, ERYTHROMYCIN, FERROUS SULFATE, FLUTICASONE PROPIONATE, GABAPENTIN, GABAPENTIN, EMPAGLIFLOZIN, LEVOTHYROXINE SODIUM, LIDOCAINE PATCH 5%, NAPROXEN, PALIPERIDONE PALMITATE, PANTOPRAZOLE SODIUM, POSACONAZOLE, POSACONAZOLE, ROSUVASTATIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, VILAZODONE HYDROCHLORIDE, VILAZODONE HYDROCHLORIDE, INSULIN ASPART, INSULIN GLARGINE, PETROLATUM, WHITE PETROLATUM, ISHANCARE HEMORRHOID CREAM, TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 178 | 25105318 |
US |
62 | 2 |
Cardiac arrest, Blood glucose increased, Brain neoplasm, Vertigo, Ataxia, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN ASPART, |
||||
| 179 | 25105324 |
US |
53 | 2 |
Pilonidal disease, Fatigue, Cataract, Somnolence, Malaise, Pain, Blood glucose increased, Decreased appetite, Dizziness, Blood glucose decreased, |
||||
TIRZEPATIDE, INSULIN LISPRO-AABC, MIFEPRISTONE, MIFEPRISTONE, MIFEPRISTONE, MIFEPRISTONE, CHLORTHALIDONE, DAPAGLIFLOZIN, INDOMETHACIN, METOPROLOL TARTRATE, METOPROLOL, INSULIN DEGLUDEC, LORAZEPAM, EZETIMIBE, ALPRAZOLAM, |
||||
| 180 | 25105328 |
US |
25 | 1 |
Diabetic ketoacidosis, Blood glucose increased, Nausea, Headache, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 181 | 25105431 |
US |
1 | |
Neoplasm malignant, Prostatic specific antigen increased, Mean cell haemoglobin concentration decreased, Immature granulocyte count increased, Blood alkaline phosphatase increased, Red blood cell count decreased, Haemoglobin decreased, Haematocrit decreased, Red cell distribution width increased, Monocyte count increased, Lymphocyte count decreased, Serum ferritin increased, Vitamin B12 increased, Blood testosterone decreased, Blood chloride increased, Blood glucose increased, |
||||
| 182 | 25105928 |
US |
73 | 2 |
Dehydration, Somnolence, Dizziness, Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 183 | 25105934 |
US |
68 | 1 |
Loss of consciousness, Hyperhidrosis, Chills, Tremor, Blood glucose increased, Nausea, |
||||
INSULIN LISPRO, |
||||
| 184 | 25105938 |
US |
29 | 1 |
Weight decreased, Product storage error, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 185 | 25106087 |
IN |
64 | 1 |
Death, Flatulence, Hyperchlorhydria, Dyspnoea exertional, Tremor, Hunger, Dizziness, Back pain, Diarrhoea, Gait disturbance, Paraesthesia, Asthenia, Coordination abnormal, Balance disorder, Hypersomnia, Dysuria, Somnolence, Waist circumference increased, Gait inability, Decreased activity, Abdominal distension, Blood glucose increased, Low density lipoprotein increased, Albumin globulin ratio increased, Serum ferritin decreased, Globulins increased, Musculoskeletal stiffness, Full blood count decreased, Joint range of motion decreased, Muscle tightness, Nasopharyngitis, Respiratory rate increased, Productive cough, Negative thoughts, Pyrexia, Cough, Swelling, Blood cholesterol increased, Blood triglycerides increased, Fatigue, Peripheral swelling, Weight increased, Irritability, Respiratory disorder, Anxiety, Pain in extremity, Pain, Decreased appetite, Haemoglobin decreased, Blood sodium decreased, Dizziness postural, Dyspnoea, Muscular weakness, |
||||
LORLATINIB, LORLATINIB, LORLATINIB, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 186 | 25106651 |
RU |
||
Poisoning, Pancreatitis, Dizziness, Headache, Nausea, Blood glucose increased, Chest discomfort, Pain, Weight increased, Increased appetite, Feeling abnormal, Limb discomfort, Lethargy, |
||||
DOLUTEGRAVIR SODIUM, LAMIVUDINE, LAMIVUDINE ORAL, |
||||
| 187 | 25107356 |
US |
2 | |
Blood glucose increased, Mental status changes, |
||||
LECANEMAB, |
||||
| 188 | 25107383 |
US |
36 | 2 |
Blood glucose increased, Product dose omission issue, Vision blurred, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 189 | 25107431 |
PY |
||
Urinary tract infection, Blood glucose increased, |
||||
GALSULFASE, |
||||
| 190 | 25114104 |
56 | 2 | |
Fatigue, Visual impairment, Blood glucose increased, Therapy interrupted, |
||||
PALBOCICLIB, AMOXICILLIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 191 | 25114140 |
56 | 2 | |
Fatigue, Visual impairment, Blood glucose increased, |
||||
INAVOLISIB, PALBOCICLIB, |
||||
| 192 | 25097538 |
US |
53 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 193 | 25097587 |
US |
42 | |
Blood glucose increased, Product dose omission issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 194 | 25097716 |
US |
66 | 2 |
Pancreatitis, Drug ineffective, Blood glucose increased, |
||||
DULAGLUTIDE, INSULIN GLARGINE, |
||||
| 195 | 25097773 |
BR |
2 | |
Cholecystectomy, Blood glucose increased, Diarrhoea, Drug ineffective, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 196 | 25097841 |
US |
71 | 2 |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 197 | 25097979 |
US |
40 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 198 | 25098062 |
CA |
66 | 2 |
Blood glucose increased, Device failure, Liquid product physical issue, Product quality issue, Product use in unapproved indication, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 199 | 25098105 |
IN |
||
Nephrolithiasis, Blood glucose increased, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, SITAGLIPTIN, AMLODIPINE, MICONAZOLE, MICONAZOLE NITRATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 200 | 25098260 |
JP |
77 | 1 |
Pneumonia, Blood glucose increased, Sepsis, Palmar-plantar erythrodysaesthesia syndrome, Pyrexia, |
||||
INSULIN HUMAN, INSULIN GLARGINE, SITAGLIPTIN, SITAGLIPTIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28